Research Tool Licensing | RaQualia Pharma Inc.

Home
Research and Development
Research Tool Licensing

When a company has a licensing agreement for research tools with a university or public research institution, there are two kinds of licenses: exclusive licenses to market patented products and non-exclusive licenses for research objectives.

Non-exclusive licenses for research tools are clearly endorsed in guidelines issued by the U.S. National Institutes of Health in 1999.

Licensing Approach 1

Licensing Approach 2

*Technology Licensing Organization

Corporate Information: CEO Message; Company Overview; Vision, Management Principle and Culture; Corporate Governance; Business Model; Origins of Our Corporate Name and Logo; Facilities; Access; Press Release
Research & Development: Collaboration; Partnering in Research; What are Research Tools?; Research Tool Licensing

Product Information: Anidulafungin; Ziprasidone; Dalbavancin; EP₄ Antagonist; Cyclooxygenase-2 (COX-2) Inhibitor; Ghrelin Receptor Agonist; 5-HT₄ Partial Agonist; Acid Pump Antagonist; 5-HT_2B Antagonist; CB₂ Agonist; Motilin Receptor Agonist; Licensing

Shareholder and Investor Information

To our Shareholders and Investors

Vision, Management Principle and Culture

Corporate Governance

Stock Quotes

Outline of Securities Matters

Understanding RaQualia Pharma! RaQualia FAQ: RaQualia's History; What does RaQualia Pharma do?; How Does RaQualia Earn Revenues?; What About Dividends?; What are RaQualia's strengths?; What Does the Future Hold for RaQualia Pharma?

Corporate Introduction Video
Contributions to Society: Corporate Contributions; Contributions to the Community; Press Release; Topics